相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monitoring blood flow responses during topical ALA-PDT
Theresa L. Becker et al.
BIOMEDICAL OPTICS EXPRESS (2011)
Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to Docetaxel in CRMPC
Roberto Pili et al.
CLINICAL CANCER RESEARCH (2010)
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy
Baozhong Zhao et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Monitoring photobleaching and hemodynamic responses to HPPH-mediated photodynamic therapy of head and neck cancer: a case report
Ulas Sunar et al.
OPTICS EXPRESS (2010)
An overview of topical photodynamic therapy in dermatology
Sally H. Ibbotson
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2010)
Taking treatment decisions in non-melanoma skin cancer-The place for topical photodynamic therapy (PDT)
A. Sidoroff et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2010)
Simulations of Measured Photobleaching Kinetics in Human Basal Cell Carcinomas Suggest Blood Flow Reductions During ALA-PDT
Ken Kang-Hsin Wang et al.
LASERS IN SURGERY AND MEDICINE (2009)
Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800 mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
Mark J. McKeage et al.
LUNG CANCER (2009)
The Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid Improves the Antitumor Efficacy and Shortens Treatment Time Associated with Photochlor-sensitized Photodynamic Therapy In Vivo
Mukund Seshadri et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2009)
Guidelines for topical photodynamic therapy: update
C. A. Morton et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial
K. Mosterd et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Irradiance-dependent photobleaching and pain in δ-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas
William J. Cottrell et al.
CLINICAL CANCER RESEARCH (2008)
Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate
Henriettte S. de Bruijn et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2008)
The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer
Mark J. McKeage
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Hemodynamic responses to antivascular therapy and ionizing radiation assessed by diffuse optical spectroscopies
Ulas Sunar et al.
OPTICS EXPRESS (2007)
A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma
L. Berroeta et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Visualizing the acute effects of vascular-targeted therapy in vivo using intravital Microscopy and magnetic resonance imaging:: Correlation with endothelial apoptosis, cytokine induction, and treatment outcome
Mukund Seshadri et al.
NEOPLASIA (2007)
Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study
Ulas Sunar et al.
JOURNAL OF BIOMEDICAL OPTICS (2006)
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX
David A. Bellnier et al.
LASERS IN SURGERY AND MEDICINE (2006)
Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer
Nicolas Solban et al.
CANCER RESEARCH (2006)
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models
QY Zhou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5-aminolaevulinic acid photodynamic therapy
J Fransson et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2005)
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: Implications for combination therapy
M Seshadri et al.
CLINICAL CANCER RESEARCH (2005)
Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy
GQ Yu et al.
CLINICAL CANCER RESEARCH (2005)
Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy
B Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors
BW Henderson et al.
CANCER RESEARCH (2004)
Relationship between tumour enclothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice
LM Ching et al.
BRITISH JOURNAL OF CANCER (2004)
Photodynamic therapy with aminolevulinic acid topical solution and visible blue, light in the treatment of multiple actinic keratoses of the face and scalp - Investigator-blinded, phase 3, multicenter trials
DJ Piacquadio et al.
ARCHIVES OF DERMATOLOGY (2004)
Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study
S Ahmadi et al.
EXPERIMENTAL DERMATOLOGY (2004)
Vascular-targeting therapies for treatment of malignant disease
DW Siemann et al.
CANCER (2004)
Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources
C Clark et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2003)
Fluorescence contrast and threshold limit:: implications for photodynamic diagnosis of basal cell carcinoma
MB Ericson et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2003)
Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models
SA Hill et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-I knockout mice
L Zhao et al.
BRITISH JOURNAL OF CANCER (2002)
Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
LM Ching et al.
BRITISH JOURNAL OF CANCER (2002)
Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin™)
SI Moriwaki et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2001)
In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies
C Cheung et al.
PHYSICS IN MEDICINE AND BIOLOGY (2001)
Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model
B Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial
I Wang et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Photodynamic therapy of skin cancers: Sensitizers, clinical studies and future directives
FS De Rosa et al.
PHARMACEUTICAL RESEARCH (2000)
Basal cell carcinomas in mice overexpressing Gli2 in skin
M Grachtchouk et al.
NATURE GENETICS (2000)
分享论文
